US FDA Targets Expanding Conduit For Supplement GMP Compliance Information

Gathering GMP information can be as problematic for agency as keeping tabs on all supplements available to US consumers. “Just to be clear, FDA believes we have a data gap in understanding the extent of the dietary supplements in the marketplace,” says ODSP Director Cara Welch.

• Source: Shutterstock

More from Regulation

More from Policy & Regulation